CERTAINTY – Japan
GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical…
Certara2024 年 5 月 7 日
CERTAINTY – South Korea
GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical…
Certara2024 年 5 月 7 日
Certara Reports First Quarter 2024 Financial Result
Reiterates Full Year 2024 Financial Guidance PRINCETON, N.J.— May 7, 2024-- Certara, Inc. （纳斯达克股票代码：CERT), a…
Certara2024 年 5 月 7 日
A Best Practice Guide to CDISC SDTM Mapping
Complete the form to book your no-obligation demo of Pinnacle 21 and experience the transformative…
Certara2024 年 5 月 7 日
Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future
The article "Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future" by Karen Rowland…
Certara2024 年 5 月 6 日
Prediction of Pediatric Pharmacokinetics for CYP3A4 Metabolized Drugs: Comparison of the Performance of Two Hepatic Ontogeny Within a Physiologically Based Pharmacokinetic Model
The rapid growth in the use of pediatric physiologically based pharmacokinetic (PBPK) models, particularly for…
Certara2024 年 5 月 6 日
RAPS Sponsored Webcast: Regulatory & Tech Advances in Drug Safety Reporting
Meeting the escalating global demand for new medications requires expediting regulatory submission development. Documenting drug…
Certara2024 年 5 月 3 日
The Neuroplatform: Towards a Comprehensive Mechanistic QSP Model of Alzheimer’s Disease for Supporting Drug Discovery and Development
With over 55 million people diagnosed worldwide, Alzheimer's disease presents a significant public health challenge,…
Certara2024 年 4 月 29 日
